Status:
COMPLETED
Microscopic-spectroscopic Examination for Urothelial Tissue Characterization
Lead Sponsor:
Careggi Hospital
Conditions:
Bladder Tumor
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate the possibility to properly discriminate between healthy bladder tissue and BCa with a multimodal fiber optic spectroscopy (MFOS) technique, in order to possibly introduce a more objective...
Detailed Description
Observational single center study on human biological samples to evaluate the possibility to discriminate between healthy and tumor tissue on urothelial bladder samples. Aim of the study is to provide...
Eligibility Criteria
Inclusion
- willingness to participate,
- legal age,
- full capacity to sign informed consent
- eligibility for each surgical operation according to the best clinical practice and the urological guidelines
Exclusion
- concomitant use of Hexaminolevulinate (Hexvix®)
- concomitant ongoing UTIs,
- concomitant bladder stone presence,
- recent catheterization or persistent bladder catheterization at time of surgery,
- concomitant presence of other pelvic cancer (both prostate, urethral, uterine),
- previous chemotherapy or radiotherapy of the pelvis,
- patient refusal at informed consent.
Key Trial Info
Start Date :
November 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT04310813
Start Date
November 1 2016
End Date
March 1 2020
Last Update
March 18 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.